set at the maximum speed (5 x 1O s at 0C). The receptor preparation was suspended at a concentration of 2 g in 10 ml of assay buffer (0.05 M, Tris-buffer, pH 7.5, containing 0.1 % BSA, 5 mM MgCI2 and 0.1 M sucrose).
The prostate is now well established as a gland with endocrine activity by virtue of the presence in it of a number of regulatory peptides, such as endorphins (Tsong et al., 1982) , vasopressin and oxytocin (Adashi & Hsueh, 1981) , relaxin (Cameron et al., 1982) , somatostatin (Di Sant Agnese & de Mesy-Jensen, 1984) and inhibin (Sathe et al., 1987; Vanage et al., 1989) . The synthesis of prostatic inhibin, like that of gonadal inhibin, is under the control of follicle stimulating hormone (FSH) (Vanage et al., 1989) . In view of the large concentration of inhibin in human prostate (Vaze et al., 1979) , one could speculate regarding the presence of FSH in human prostate.
The incidence of prostatic disorders (both benign and malignant) increases with age and circulating FSH levels also rise in ageing men . Whether this increased FSH has any role to play in the pathophysiology of the prostate needs to be investigated. In this paper, we report the immunocytochemical localisation of FSH-like peptide in normal, benign and malignant prostates and the comparative distribution pattern of immunoreactive FSH in these conditions.
Materials and methods
Prostate specimens, normal (eight), benign prostatic hyperplasia (BPH) (25) (Reichert & Abou-Issa, 1977) . The receptor preparations were suspended at a concentration of I g in 10 ml in the assay buffer.
Human FSH (hFSH-13) was iodinated by the chloramine-T method (Reichert & Bhalla, 1974) urinary bladder, rectum and oesophagus were unstained. Normal All specimens from age 9 years onwards showed positive staining for FSH in prostatic epithelial cells. However, the prostate specimens from age I to 8 years were negative for FSH.
Nodules and tumours
The hyperplastic glands were identified on the basis of a large number of nodules having papillary epithelial infoldings, stellate lumina and mostly double layered epithelial cell lining. The staining for FSH was intense in these hyperplastic glands and was localised in the cytoplasm of the columnar epithelial cells (Figures 3 and 7) . The secretory material in the lumen of the glands showed positive reaction in many of BPH specimens (Figure 3) . In some areas of BPH, an alternating Interestingly, in a few cases of BPH as well as malignant specimens, faint positive reaction was observed in the smooth muscle bundles of the stromal tissue ( Figure 5 ). In some BPH specimens, the secretory material was observed in the form of blobs emerging from the apical portion of the cell (Figure 6 ).
The intensity of the reaction was varied in moderately differentiated carcinomas. Epithelial cells of some glands 4 exhibited intense positive reaction while in the adjoining glands they were faintly stained (Figure 8 ). The epithelial cells in poorly differentiated carcinomas also exhibited marked variation in staining but all specimens examined were positive for FSH (Figure 9 ). Human prostatic endocrine-paracrine cells (amine precusor uptake and decarboxylation, APUD, cells) were first des- cribed by Pretl in 1944 and further studied by Feyrter in 1951. The importance of the prostate gland as an endocrine organ is supported by the recent identification of several peptides in this gland, including endorphins (Tsong et al 1982) , vasopressin and oxytocin (Adashi & Hsueh, 1981) , relaxin (Cameron et al., 1982) , somatostatin (Di Sant Agnese & de Mesy-Jensen, 1984) , inhibin (Sathe et al., 1987; Vanage et al., 1989) and insulin (Stahler et al., 1988) . Contrary to earlier concepts, it now appears that regulatory peptides are widely distributed and are involved in various functions that are beyond those classically recognised for these peptides. In correlation with this concept, our present study demonstrates immunocytochemical staining for FSH or FSH-like peptide in epithelial cells of human prostate, whether normal benign or malignant. The specificity of staining for immunoreactive FSH is established by positive controls (pituitary and testis) and negative controls (oesophagus, urinary bladder, rectum and epididymis). Our findings are in agreement with earlier observation made by Harper and Griffith (1982) , who reported positive immunocytochemical localisation of FSH in the prostatic specimens from 11 BPH patients. In the present study, weakly positive staining of stromal cells was observed in few specimens from benign and malignant prostates. In our other studies, we have observed stromal cells showing strong positive staining for hLH and rather faint in epithelial cells (unpublished data). In the light of the above observa-tion, whether the weak immunochemical staining observed for FSH in stromal cells of some samples is due to a common alpha-subunit of FSH and LH remains to be determined.
Epithelial cells from normal prostate showed a positive reaction, indicating the presence of immunoreactive FSH during the prepubertal stage. The maximum intensity was observed in cases of BPH where the staining was granular and coarse. The blob-like secretion of immunoreactive FSH often seen in BPH sections provides an explanation for the presence of FSH in human semen reported earlier (Biswas et al., 1978; Fossati et al.,1979) . In both moderately and poorly differentiated carcinomas, the positive reaction was focal and of varied intensity within the same tumour. As compared to other prostatic antigens, i.e. prostatic acid phosphatase and prostate specific antigen, we have previously shown that prostatic inhibin peptide appears to be a vital product as it persists in epithelial cells of poorly differentiated prostatic carcinoma when these cells have become negative for the above mentioned antigens (Sheth et al., 1988 The changes in the intensity as well as the pattern observed for FSH and inhibin (Doctor et al., 1986; Sheth et al., 1987) were similar. With this knowledge, it is tempting to speculate that in the prostate FSH plays a regulatory role in inhibin biosynthesis. This is in agreement with our earlier observation that exogenous/endogenous FSH is involved in the modulation of inhibin concentrations of rat prostate (T.R. Teni et al., in preparation) .
Inhibin has been well demonstrated to be involved in prostatic growth and differentiation by virtue of its effect of polyamine biosynthesis (Natraj et al., 1986) and steroidogenesis (Joseph et al., 1987) . It is therefore plausible that FSH, either directly or by modulating inhibin levels, could be involved in the aetiopathology of the prostate. Earlier studies in animals indicated that pituitary hormones could influence prostatic growth and function, since a more marked atrophy of the rat prostate gland was observed after hypophysectomy and castration, than after castration alone (Lostroh et al., 1957 (Biswas et al., 1978; Fossati et al., 1979) it is not yet elucidated whether or not it enters the circulation. Recently Yoon et al. (1987) have demonstrated the immunocytochemical localisation of FSH in human testis. This report supports our findings that FSH can be synthesised by non-pituitary tissues.
In view of the well established growth regulatory role of FSH in gonads and its role in modulating inhibin biosynthesis in human prostate glands (Vanage et al., 1989) it would be of interest to evaluate the autocrine or paracrine roles of FSH in the aetiopathology of prostatic diseases.
